PITTSFORD, N.Y. (AP) — Bills defensive tackle Kyle Peko was torn over whether to report to training camp after his wife, Giuliana, was diagnosed with Stage 3 Hodgkin's lymphoma.
OAKLAND, Calif. (AP) — A judge has cut a jury award in a lawsuit that found that Monsanto's Roundup herbicide caused cancer in a California couple from $2.055 billion to $87 million, the third...
SAN FRANCISCO (AP) — A U.S. judge lowered a jury's damage award from $80 million to $25 million for a California cancer victim who used Monsanto's Roundup weed-killer.
COLUMBIA, Mo. (AP) — Former Missouri football coach Gary Pinkel says he is being treated for cancer again.
Pinkel told ABC17 TV in Columbia Saturday that he had treatment last month after...
SAN FRANCISCO (AP) — A jury on Monday ordered agribusiness giant Monsanto Co. to pay a combined $2.055 billion to a couple claiming that the company's popular weed killer Roundup Ready caused...
The Latest: Monsanto to appeal $80M award over Roundup
SAN FRANCISCO (AP) — The Latest on a California man's lawsuit claiming Roundup weed killer caused his cancer (all times local):
SAN FRANCISCO (AP) — Roundup weed killer was a substantial factor in a California man's cancer, a jury determined Tuesday in the first phase of a trial that attorneys said could help determine the...
LAS VEGAS (AP) — Casino magnate and major GOP donor Sheldon Adelson is battling cancer, but industry analysts and his Las Vegas Sands Corp. on Friday said the gambling empire he founded and helms...
Germany’s Bayer vows strong defense in Roundup cancer cases
BERLIN (AP) — Germany's Bayer AG, which bought Monsanto Co. last year, has underlined its determination to fight cases involving the Roundup weed-killer in the face of more than 11,000 lawsuits so...
High-stakes trial starts in Roundup weed killer cancer claim
SAN FRANCISCO (AP) — A jury in federal court in San Francisco will decide whether Roundup weed killer caused a California man's cancer in a trial starting Monday that plaintiffs' attorneys say...
Monsanto appeals $78M verdict in California weed killer suit
SAN FRANCISCO (AP) — Agribusiness giant Monsanto on Tuesday appealed a $78 million verdict in favor of a dying California man who said the company's widely used Roundup weed killer was a major factor in his cancer.
The company filed a notice of appeal in San Francisco Superior Court challenging a jury verdict in favor of DeWayne Johnson. In August, the jury unanimously found that Roundup caused Johnson's non-Hodgkin's lymphoma and awarded him $289 million.
Houston’s Hal returns to practice after fight with cancer
HOUSTON (AP) — Safety Andre Hal, who is in remission after being diagnosed with Hodgkin lymphoma, resumed practicing with the Houston Texans on Wednesday, giving the team 21 days to take him off the non-football illness list and add him to the active roster.
Hal was diagnosed with the disease in May and immediately began treatment. He received the news of his remission on Sept. 18.
DC United’s Odoi-Atsem diagnosed with Hodgkin’s lymphoma
WASHINGTON (AP) — D.C. United says defender Chris Odoi-Atsem has been diagnosed with Hodgkin's lymphoma and is scheduled to have four months of chemotherapy.
The 23-year-old was drafted 12th overall by D.C. United in 2017 and has made a total of 10 appearances, with five starts, over the past two seasons for the MLS club.
Paul Allen says his non-Hodgkin’s lymphoma has returned
SEATTLE (AP) — Billionaire Seattle Seahawks owner and Microsoft co-founder Paul Allen says cancer he was treated for in 2009 has returned.
Allen said on Twitter Monday that he recently learned of the non-Hodgkin's lymphoma and plans to fight it aggressively.
He says there have been advances in medicine since he overcame the disease nearly a decade ago and that he and his doctors are optimistic that he will see good results from the latest therapies.
Texans safety Andre Hal’s Hodgkin lymphoma is in remission
HOUSTON (AP) — Houston Texans safety Andre Hal's Hodgkin lymphoma is in remission.
Hal was diagnosed with the disease in May and immediately began treatment. He received the news of his remission on Sept. 18. He chose not to undergo chemotherapy, instead opting for a less aggressive form of treatment with hopes of returning to the field this season.
Along with his medical treatment he also used non-traditional forms of treatment such as acupuncture to aid in his healing efforts.
Monsanto asks judge to throw out $289M award in cancer suit
SAN FRANCISCO (AP) — Agribusiness company Monsanto has asked a San Francisco judge to throw out a jury's $289 million award to a former school groundskeeper who said the company's Roundup weed killer left him dying of cancer.
DeWayne Johnson failed to prove that Roundup or similar herbicides caused his non-Hodgkin's lymphoma, and presented no evidence that Monsanto executives were malicious in marketing Roundup, attorneys for Monsanto said in court documents filed late Tuesday.
Jury awards $289M to man who blames Roundup for cancer
SAN FRANCISCO (AP) — A jury's $289 million award to a former school groundskeeper who said Monsanto's Roundup left him dying of cancer will bolster thousands of pending cases and open the door for countless people who blame their suffering on the weed killer, the man's lawyers said.
"I'm glad to be here to be able to help in a cause that's way bigger than me," Dewayne Johnson said at a news conference Friday after the verdict was announced.
- The Spokesman-ReviewU-Hi twin sisters win charity-giving competitionJuly 4, 2019
- The Washington TimesChris Odoi-Atsem of D.C. United diagnosed with Hodgkin's lymphomaOctober 16, 2018
- Beatrice Daily SunDon't Let Hodgkin Lymphoma Hold You Back: Jennifer's Story of Perseverance May Help Newly Diagnosed PatientsOctober 12, 2018
- Wisconsin State JournalCellectar says tumors shrank as much as 90 percent in early trials of its lead cancer drugAugust 12, 2018
- Capital JournalPeter Gabriel to launch medical streaming serviceMay 1, 2018
EAST RUTHERFORD, N.J. (AP) — New York Giants general manager Dave Gettleman says the aggressive cancer he was diagnosed with last month is in remission.
Speaking to the media for the first time since the Giants disclosed in early June that he had lymphoma, Gettleman said Friday he's had four rounds of chemotherapy and will need another three more to complete his treatment.
SAN FRANCISCO (AP) — Hundreds of lawsuits alleging Roundup weed killer caused cancer cleared a big hurdle Tuesday when a U.S. judge ruled that cancer victims and their families could present expert testimony linking the herbicide to non-Hodgkin's lymphoma.
SAN FRANCISCO (AP) — Lawyers for a school groundskeeper dying of cancer asked a San Francisco jury on Monday to find that agribusiness giant Monsanto's widely used weed killer Roundup likely caused his disease.
Dewayne Johnson's lawsuit is the first case to go to trial among hundreds of lawsuits saying Roundup caused non-Hodgkin's lymphoma.
HOUSTON (AP) — Houston Texans safety Andre Hal has been diagnosed with Hodgkin lymphoma and insists he "will beat it."
He received the preliminary diagnosis of cancer of the blood cells from team physician Dr. James Muntz and has consulted with doctors at Houston's MD Anderson Cancer Center, the team said Friday.
The Texans added that Hal is "undergo testing and evaluation and is discussing his treatment options."
New York Giants GM Dave Gettleman has lymphoma
EAST RUTHERFORD, N.J. (AP) — New York Giants general manager Dave Gettleman has lymphoma and will soon begin treatment, and he said he is encouraged by the prognosis.
SYRACUSE, N.Y. (AP) — Police say a central New York couple pretended their 9-year-old son had blood cancer in order to solicit money from sympathetic donors, even receiving an invite to Syracuse University football practice from the ruse.
‘I wasn’t going to be scared of this’: Firefighter beat cancer twice, now waits for baby girl’s arrival
May 19 was the worst day of Nick Howe’s life.
Worse, even, than the day the summer before when he was diagnosed with cancer. Because in May 2017, Howe learned that his lymphoma had returned. And this time, the disease was more aggressive.
The first time, Howe, a 33-year-old firefighter at Eppley Airfield, was winding down at work one night when he ran his hand along his neck. He paused as he felt a lump.
SAN FRANCISCO — Claims that the active ingredient in the widely used weed killer Roundup can cause cancer have been evaluated by international agencies, U.S. and foreign regulators and the product’s manufacturer — agribusiness giant Monsanto.
Now, a federal judge in San Francisco is conducting his own review during an unusual set of court hearings that began Monday. It has big stakes for Monsanto and hundreds of farmers and others who have sued the company.
SAN FRANCISCO (AP) — A federal judge on Monday waded into the arcane science behind claims that the widely used weed killer Roundup can cause cancer. The expected weeklong testimony is intended to help him determine whether a jury should hear from doctors who link the product to non-Hodgkin's lymphoma.
- Business WireEpizyme Reports Business Progress and Second Quarter 2019 ResultsAugust 9, 2019
- Business WireGamida Cell Reports Second Quarter 2019 Financial Results and Provides Company UpdateAugust 6, 2019
- Business WireRituxan Drug Overview 2019: 2017 Arrival of a Biosimilar Version of Rituxan in the EU Further Dampens Rituxan's Commercial Attractiveness - ResearchAndMarkets.comJuly 12, 2019
- Globe NewswireRedHill Biopharma Announces FDA Acceptance of New Drug Application for Talicia®July 3, 2019
- Business WireGlobal Aliqopa (copanlisib; Bayer) Drug Overview & Product Profiles 2017-2026 - ResearchAndMarkets.comJune 28, 2019
SAN FRANCISCO (AP) — The Latest on a hearing in San Francisco on lawsuits claiming the active ingredient in the Roundup weed killer can cause cancer(all times local):
A University of California, Los Angeles epidemiologist has testified that she believes the active ingredient in Monsanto's widely used weed killer Roundup can cause cancer.
Beate Ritz explained during an unusual federal court hearing in San Francisco on Monday how she evaluated studies to reach her conclusion.
TAMPA, Fla. (AP) — A Florida teen who was initially diagnosed with the flu is now being treated for cancer.
WFTS news reported this week that 16-year-old Hunter Brady is undergoing rounds of chemotherapy at a Tampa children's hospital as he fights stage 4 Hodgkin's lymphoma.
The Latest: Officials couldn’t connect line to inmate
ATMORE, Ala. (AP) — The Latest on the scheduled execution of an Alabama inmate (all times local):
Alabama's prison commissioner says the state halted an inmate's execution by lethal injection because medical staff were having difficulty connecting an intravenous line.
Nebraska Medicine offers new treatment for lymphoma, leukemia patients with no other option
When Amy Cheese came to the Nebraska Medical Center in October 2016, she had a tumor the size of a grapefruit in her chest, next to her heart and lungs.
She’d already been through three rounds of chemotherapy over the course of a year, but her non-Hodgkin lymphoma had rebounded.
About a month later, she participated in a clinical trial for a new type of therapy in which her immune cells were removed from her body and genetically engineered to recognize and attack her cancer.
People with certain types of recurring blood cancers now can receive a new form a treatment at Nebraska Medicine in Omaha.
Chimeric antigen receptor T-cell therapy was approved Monday for commercial use by the U.S. Food and Drug Administration. The therapy, meant for patients with recurring non-Hodgkin lymphoma, and pediatric or young-adult acute lymphoblastic leukemia, is among a growing number of cancer-treatment options that harness the body's immune system to attack tumors.
When everyone else rushes away from an emergency, firefighters are often the first ones rushing in to help.
Maryland governor announces he has ‘non-serious skin cancer’
ANNAPOLIS, Md. (AP) — Maryland Gov. Larry Hogan, who says he remains in remission from non-Hodgkin's lymphoma, announced Thursday he has been diagnosed with "very non-serious skin cancer."
Hogan had some skin removed last month from his forehead as part of regular trips he makes to the dermatologist. The governor said it turned out to be basal-cell and squamous-cell skin cancer, but not melanoma, which is a serious form of skin cancer.
STURGIS — Medical tests may show otherwise, but Sturgis teacher and city council member Scott Peterson says he certainly doesn’t feel sick, though he was diagnosed with B Cell lymphoma cancer on Nov. 15.
Because he doesn’t really feel sick, Peterson said he was surprised at the effort of friends to do a fun-run fundraiser for him recently.
“I was overwhelmed by the support,” he said.
The run was cancelled because of cold weather, but organizers hope to reschedule.
Stanford linebacker Ryan Beecher says he has lymphoma
STANFORD, Calif. (AP) — Stanford junior inside linebacker Ryan Beecher has announced he is receiving treatment for non-Hodgkin's lymphoma but will remain enrolled in classes and looks forward to making a full recovery. He also hopes to contribute again to the Cardinal football team.
Clemson student overcomes cancerous tumor growing in chest
GREENVILLE, S.C. (AP) — A year ago, Brittain Bass was just coming to grips with being told he had Hodgkin's lymphoma.
"Twenty-three-year-olds don't get cancer," he told The Greenville News at the time. "You never think about it happening to you."
But a tumor was indeed growing in his chest and it had wrapped itself around the arteries near his heart. It could not be surgically removed.
Cancer survivor Quessenberry to make NFL debut for Texans
HOUSTON (AP) — During the really tough times as he fought to overcome cancer, David Quessenberry would daydream about reaching his lifelong goal of playing in an NFL game.
It was a plan that was derailed when he was diagnosed with non-Hodgkin's lymphoma, and put on hold for years as he underwent treatment for the disease.
Communities rally behind Mason County native battling Hodgkin’s lymphoma
The friends and family members of Mason County native Cody Hodges have one wish this Christmas — to help fund Cody’s treatment for Hodgkin’s lymphoma.
Cody — a 30-year-old Mason County Central, West Shore Community College and Western Michigan University alumnus from Custer — received his diagnosis earlier this year, and has been undergoing chemotherapy treatments for the illness.
‘Booze Traveler’ host Jack Maxwell, 54, says he has cancer
BOSTON (AP) — Travel Channel host Jack Maxwell says he's undergoing treatment for cancer.
The personality behind the popular "Booze Traveler" series tweeted Tuesday: "I have cancer. 3 little words, one big sentence."
The 54-year-old Boston native says he's being treated in Arizona for non-Hodgkins lymphoma. He adds: "I'm good though. Keep you posted."
Cancer no match for Country Day volleyball player
NEW ORLEANS (AP) — Country Day sophomore Kate Launey still flashes a huge smile when she talks about the Cajuns' Sept. 14 match against Dominican.
It was a typical early season match between two quality programs, and the Cajuns won in four sets. Launey recorded 10 digs and two aces, but it was more than that.
AstraZeneca wins US approval for lymphoma drug
U.S. regulators have approved a new treatment for people with a rare form of non-Hodgkin lymphoma.
The Food and Drug Administration on Tuesday granted accelerated approval to AstraZeneca PLC's Calquence for people with mantle cell lymphoma after chemotherapy or other treatments fail. The British drugmaker is now conducting further testing required by the FDA to confirm the drug's benefits and risks.
Kansas hospital approves new cancer treatment
LAWRENCE, Kan. (AP) — The University of Kansas Cancer Center will be one of 16 sites nationwide approved to offer a new immunotherapy that made national headlines last week as the second commercially available treatment that uses genetic engineering to target and kill cancer cells.
US regulators approve 2nd gene therapy for blood cancer
TRENTON, N.J. (AP) — U.S. regulators on Wednesday approved a second gene therapy for a blood cancer, a one-time, custom-made treatment for aggressive lymphoma in adults.
The Food and Drug Administration allowed sales of the treatment from Kite Pharma. It uses the same technology, called CAR-T, as the first gene therapy approved in the U.S. in August, a treatment for childhood leukemia from Novartis Pharmaceuticals.
Family walk the walk after cancer battle, Seahawks visit
VANCOUVER, Wash. (AP) — In his 14 years, Ayden Mills has endured more major health issues than most adults ever face.
An infection nearly claimed his life as a toddler. The damage the infection inflicted on his little body led to years of dialysis and, eventually, a kidney transplant. A decade later, the drugs he takes to sustain his life likely caused yet another devastating diagnosis: lymphoma.
Fort Cherry senior gives lesson in making the best of a bad situation
Cancer is no laughing matter - unless you are Nicole Stewart."I was a big fan of cancer jokes about me," she said. "We had homecoming (Sept. 29) and someone said, 'You have cancer. Make a request. They'll play any song you want.'"I tell bad jokes all the time. The more I tell bad jokes, the more everyone appreciates good ones."The first half of 2017 was a horrifically bad joke to Stewart, but one she characteristically laughs off today. In January, halfway through her junior year at Fort Cherry...
One year ago, Xavier Hinojosa had just been diagnosed with Stage 4 Hodgkin’s lymphoma.
But as bad as that might sound, Xavier and his family marked National Childhood Cancer Awareness Month during September by celebrating the fact he has been in remission for six months.
Pfizer scientist shares story of childhood cancer in national ad
Groton — Rosemary Orciari didn't hear anything for months after she submitted two sentences on her "interesting back story" last year.
Then, she was at Stop & Shop getting a cake for her daughter's birthday in January when she found out she'd be flying to New Zealand in 10 days to shoot an ad.
Gilead to pay $11.9B for cancer treatment developer Kite
Gilead Sciences will pay $11.9 billion in cash to buy Kite Pharma and plant a stake in an emerging area of cancer treatments that train a patient's immune cells to attack tumors.
Kite's portfolio of potential treatments includes one for the blood cancer lymphoma that could receive U.S. regulatory approval later this year.